Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: €0.16 M
• Last 3 months FTD volume: €0.58 M
• Last 12 months FTD volume: €12.15 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	N/A	€2.11 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	€5.36 M	€70.47 M	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	€1.71 M	€7.18 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	€2.8 M	€17.38 M	🇺🇸 USA
Thermo Fisher Scientific TMO	€26.73 M	€78.59 M	🇺🇸 USA
Esperion Therapeutics ESPR	€3.3 M	€9.95 M	🇺🇸 USA
Illumina ILMN	€5.81 M	€28.54 M	🇺🇸 USA
Ligand Pharmaceuticals LGND	€2.41 M	€9.29 M	🇺🇸 USA
Aerie Pharmaceuticals AERI	N/A	€0.94 M	🇺🇸 USA